NYSE · GSK
GSK PLC American (Each representing two )
$51.98 +$0.63 (+1.23%) 1D After hoursKey Metrics
$102.84B
Market cap
—
P/E · TTM
—
Revenue · TTM
—
Net income
EPS · TTM
—
Dividend yield
—
Free cash flow
—
Beta · 1Y
0.30
EBITDA · TTM
—
Gross margin
—
Snapshot
Market cap$102.84B
Enterprise value—
Shares outstanding2.0B
52-wk range$36.75 – $61.70
Avg volume · 20D4.3M
Net cash
—
Book value / share—
ExchangeNYSE
About GSK PLC American (Each representing two )
IPO dateAug 18, 1976
Employees66841
In the pharmaceutical industry, GSK ranks as one of the largest firms by total sales. The company wields its might across several therapeutic classes, including respiratory, antiviral, and vaccines, and has been growing its presence in oncology and immunology, as well.
Wolf Grade COMING SOON
—
The wolf is in training. Composite grades vs sector — profitability, health, value, momentum — arrive with the percentile engine. Methodology will be public.
Valuation
P/E—
P/S—
P/FCF—
EV/EBITDA—
EV/Sales—
Graham №—
Profitability
Gross
—
Operating
—
Net
—
FCF
—
ROE / ROIC
— · —
Financial Health
Current ratio—
Quick ratio—
Debt / equity—
Debt / EBITDA
—
Net cash
—
Working capital—
Cash Flow · TTM
Operating CF
—
Capex
—
Free cash flow
—
Buybacks
—
Dividends paid
—
Shareholder yield
—
Piotroski F-Score
0 / 9
Weak fundamentals · 0 of 9 signals passing
Altman Z-Score
—
Insufficient balance-sheet inputs
Graham Number vs Price
—
Requires positive earnings and book value
Fundamentals through 2025-12-31 · computed by TickerWolf from SEC filings